The largest database of trusted experimental protocols

12 protocols using cottonseed oil

1

Hormonal Priming for Hamster Sexual Behavior

Check if the same lab product or an alternative is used in the 5 most similar protocols
One or 3 weeks (viral vector studies) following surgery, female hamsters were hormone-primed for sexual behavior testing via subcutaneous injections of 10 μg of estradiol benzoate (Sigma-Aldrich, St. Louis, MO, USA) in 0.1 mL of cottonseed oil (Sigma-Aldrich) at approximately 48 and 24 h prior to the sexual behavior test, followed by a subcutaneous injection of progesterone (500 μg in 0.1 mL of cottonseed oil, Sigma-Aldrich) 4 h prior to the testing. Females were paired with a male hamster in either the biosensor testing chamber or in the female’s home cage for a 10 min session. Copulatory parameters of the females (lordosis latency and total lordosis duration) and males (mounts, intromissions, ejaculations) were obtained to ensure that the females received comparable levels of sexual stimuli. For c-Fos experiments, control females were not given a sexual behavior test following hormonal priming; instead their cage was placed in the same behavioral testing room with the male hamsters present for 10 min. In the DREADD experiment, female hamsters were given either 5 mg/kg CNO in 0.9% saline (Enzo Life Sciences, Farmingdale, NY, USA) or an equivalent volume of saline (0.1 mL/100 g body weight) 30 min prior to behavioral testing.
+ Open protocol
+ Expand
2

Cottonseed Oil Dosing in Neonatal Hyperoxia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cottonseed oil (Sigma-Aldrich, Darmstadt, Germany; C7767) was applied by daily intraperitoneal injection to pups, where the Cottonseed oil dose was de-escalated over a range starting at 20 ml kg−1 day−1 (P1, P2, P3), followed by 15 ml kg−1 day−1 (P4, P5, P6), then by 10 ml kg−1 day−1 (P7, P8, P9) and finally to 5 ml kg−1 day−1 (P10, P11, P12, and P13), to avoid the injection of a large oil bolus. The experiment was terminated at P14. The Cottonseed oil application was undertaken in the BPD model using either continuous exposure to 60% O2 (FiO2 0.60) or 85% O2 (FiO2 0.85). The application of Cottonseed oil was in analogy with generic oil-based nutritional supplementation that is provided to preterm infants with or at risk for BPD in a neonatal intensive care setting (Beken et al., 2014 (link)).
+ Open protocol
+ Expand
3

Comprehensive Fatty Acid Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A fatty acid methyl ester (FAME) standard mixture containing all relevant fatty acid methyl esters was obtained from USP (Rockville, MD). Ammonium acetate (LC-MS grade) was purchased from Honeywell (Muskegon, MI). Glyceryl tricaprylate, glyceryl tricaprate, glyceryl trimyristate, glyceryl trilaurate, glyceryl tripalmitate, and glyceryl tripalmitoleate were acquired from Santa Cruz biotechnology (Dallas, TX). Glyceryl tristearate, glyceryl trioleinate, glyceryl trilinoleate, glyceryl trilinolenate, sodium hydroxide, 2-dimethylaminoethanol (DMAE), butylated hydroxytoluene (BHT), toluene, and certified analytical standards of cottonseed oil, sunflower seed oil, palm oil, coconut oil, canola oil, linseed oil, olive oil, corn oil, and soybean oil were obtained from Sigma-Aldrich (St. Louis, MO). Optima LC/MS grade acetonitrile and water were purchased from Fisher Scientific (Pittsburgh, PA).
+ Open protocol
+ Expand
4

Deguelin and SB203580 Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deguelin was purchased from Sigma-Aldrich Co. (St Louis, MO, USA). SB203580, an inhibitor of p38 MAPK, was obtained from Selleck Chemicals Company (Houston, TX, USA). Both of the chemicals were dissolved in dimethylsulfoxide (DMSO) (Sigma-Aldrich Co.) and stored at –20°C. Cottonseed oil was purchased from Sigma-Aldrich Co.
+ Open protocol
+ Expand
5

Prostate Hyperplasia Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats were acclimatized for 1 week, followed by bilateral orchiectomies to prevent the influence of endogenous testosterone. After 1 week, rats were divided into five groups: NC, BPH, HX200, HX300, and Fina (n = 5 per group). Prostatic hyperplasia was induced in four groups (BPH, HX200, HX300, Fina) by subcutaneous injection of 3 mg/kg of testosterone propionate (TP) (Tokyo Chemical Industry, Tokyo, Japan) dissolved in cottonseed oil (Sigma-Aldrich, St. Louis, MO, USA) every three days. The NC group received only cottonseed oil in order to provide similar subcutaneous injection conditions in all groups. During the induction of prostate hyperplasia, rats orally received respective reagents on a daily basis for 4 weeks. The HX200 group and HX300 group were orally administrated 200 mg/kg of HX109 or 300 mg/kg of HX109. The Fina group was orally administrated 5 mg/kg of finasteride as a positive control. The NC group and BPH group were orally administrated distilled water as a vehicle. Body weight was measured once a week during the experiment. After 4 weeks, rats were sacrificed, and prostates were immediately removed and weighed.
+ Open protocol
+ Expand
6

Biocontrol of Locusts using Metarhizium acridum

Check if the same lab product or an alternative is used in the 5 most similar protocols

Metarhizium acridum (ARSEF-324, obtained from the Agricultural Research Service Collection of Entomopathogenic Fungal Cultures (ARSEF), Ithaca, NY) was cultured on Potato Dextrose Agar; maintained at 28 °C; and kept under continuous light. Suspensions of fungal conidia in cottonseed oil were prepared to a concentration of 3.75 × 107 per ml13 (link), 17 (link). Ten milliliters of cottonseed oil (Sigma-Aldrich, Dorset, UK) was added to 7-day old fungal cultures. Conidia were dislodged using a sterile spreader and the suspension was transferred to a sterile 25-ml bottle. The suspension was then filtered through four layers of sterile muslin to remove mycelia and clumps of conidia, centrifuged at 3000 rpm for 3 min, and then placed in a sonicating water bath at 15 °C for 5 min. The concentration of the conidial suspension was determined using a Neubauer haemocytometer and adjusted as required13 (link), 17 (link). Adult locusts were inoculated with 2 μl of fungal suspension (~75,000 conidia) under the pronotal shield using a micro-syringe (VICI®, Baton Rouge, Louisiana, USA). Controls were treated with 2 μl of cottonseed oil alone.
+ Open protocol
+ Expand
7

ATRA Dosage and Toxicity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
World Health Organization (WHO) recommended oral supplementation at 30–60 mg of ATRA for infant children 6–59 months of age [17 ]. The dosage of ATRA adjuvant chemotherapy for APL was 45 mg/m2 [23 (link)]. As reported, the median lethal dose (LD50) of ATRA in Swiss mice was 31 mg/kg by intraperitoneal injection [34 (link)], and the equivalent dose ratio for human and mice was 1:0.0026 based on the default weights of humans and mice (70 kg and 20 g) as well as their body surface areas. Considering the above facts along with the bioavailability of different administering routes, we determined that the intraperitoneal injection doses of ATRA were 1, 5, 10, 20, 40, 60, and 80 mg/kg. In addition, ATRA was divided into four doses according to its clinical application: low (1 mg/kg), medium (5 or 10 mg/kg), high (20 mg/kg), and toxic dose (40, 60, or 80 mg/kg). The ATRA powder (Sigma, St. Louis, MO, USA. R2625) was dissolved in dimethyl sulfoxide (DMSO), further diluted in cottonseed oil (Sigma, St. Louis, MO, USA. C7767) at the appropriate concentrations, and then stored at 4 °C. Mice were intraperitoneally injected with 0.2 mL ATRA solution once a day for 10 days, while the control group was injected with the same volume of cottonseed oil.
+ Open protocol
+ Expand
8

Polymer Film Infusion Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
Multilayer extruded commercial-grade polymer films (thickness ≈ 0.1 mm) obtained from Bemis Company, Inc. (Neenah, WI) were used as substrates for infusion. Most commonly, the top and bottom layers of the films were comprised of ULDPE (thickness ≈ 10 μm), while the intermediate layers were a proprietary combination of highly impermeable polymers. For oil impregnation within the ULDPE polymer matrix, cottonseed oil (Sigma Aldrich) was used. Impregnation with oil was achieved using a motorized drawdown coater (ChemInstruments, EC-100) with the smallest size coating rod (size 0). First, 100–200 μL of cottonseed oil (ρ = 925 kg/m3) was pipetted on the leading edge of the polymer film. Second, the motorized rod spread the oil uniformly across the top face of the film. After waiting for a few seconds to allow for the oil to impregnate the ULDPE, any excess oil atop the film was firmly wiped away with absorbent wipes (Kim wipes). For the control case where the oil did not impregnate the ULDPE, the same process was repeated but with 10 cSt silicone oil (Sigma Aldirch) instead of cottonseed oil. Other polymer films that were also used included medium density polyethylene (MDPE), cyclic olefin copolymer (COC), polypropylene (PP), or polyethylene terapthalate (PET) as the top layer.
+ Open protocol
+ Expand
9

Prenatal testosterone and DHT effects on ovarian development

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prenatal T and DHT-treated animals were generated by intramuscular administration of 100mg T propionate (1.2mg/kg; Sigma-Aldrich St. Louis, MO) and 100mg of DHT propionate (Steraloids) in 2mL of cottonseed oil (Sigma-Aldrich), respectively, to pregnant ewes twice weekly from days 30 to 90 of gestation. Ovaries were collected at four different ages, fetal days 90 (FD90) and 140 (FD140), and at postnatal 10 months (end of first breeding season; Year 1), and 21 months-of-age (end of second breeding season; Year 2). Only one female offspring from each mother were included in the study. As such the number represented also reflects number of mothers used in this study. The number of animals for FD140, Year 1 and Year 2 time points were 4 per treatment group, while at FD90, the number of animals in control and prenatal T groups were 4 and prenatal DHT group was 5. There were insufficient DHT-treated females born to include a Year 2 prenatal DHT-treated group. Developmental changes in ovarian follicular distribution determined by ovarian morphometry and changes in expression of apoptotic factors, steroid receptors, steroidogenic enzymes and ovarian VEGF and AMH patterns from the cohort used in this study have been previously published 14 (link),20 (link),38 (link)–42 (link)
+ Open protocol
+ Expand
10

Fluconazole Formulation Development and Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluconazole (FLZ) was received as a gift from Hasco-Lek S.A. (Wroclaw, Poland). Isopropyl myristate, castor oil, olive oil, peanut oil, cottonseed oil, sesame oil, Pluronic F127 (PLU), Tween 80 (T80), Tween 20 (T20), Kolliphor EL (KOL), polyethylene glycol 200 (PEG 200), and Span 80 were purchased from Sigma-Aldrich Chemical Company (St. Louis, MO, USA). Oleic acid (OA) and propylene glycol (PG) were obtained from Chempur (Piekary Slaskie, Poland). High-performance liquid chromatography (HPLC) grade methanol was purchased from Honeywell Specialty Chemicals (Seelze, Germany). Deuterium oxide was purchased from Armar Chemicals (Leipzig, Germany). All chemicals used in this study were of analytical grade.
Four Candida strains were involved in this study from American Type Culture Collection (Manassas, VA, USA) from the laboratory collection of the Department of Pharmaceutical Microbiology and Parasitology at the Wroclaw Medical University (C. albicans ATCC 90028, C. parapsilosis ATCC 90018, C. glabrata ATCC 90030, C. tropicalis ATCC 750). The strains were stored in trypticase soy broth with the addition of 15% glycerol and kept at −80 °C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!